Rezultaty 41 - 60 Rezultaty od 100 Dla wyszukiwania '((((justifications OR justifications) OR justification) OR modifications) OR verification)', Czas wyszukiwania: 0,07s Redukuj rezultaty
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48

    <b>The Dynamics of Sustainable Supply Chains: An Evolutionary Game of Leadership, AI Ethics, and Workforce Empowerment</b> od Rui Du (22668368)

    Wydane 2025
    “…<br>These materials support the transparency, reproducibility, and verification of the modeling and numerical results presented in the paper.…”
  9. 49

    The dataset of Co<sup>2</sup>FuLL, paper accepted by ASE'25 od Chaopeng Dong (15421424)

    Wydane 2025
    “…<p dir="ltr">This repository provides the dataset for our ASE 2025 paper: Advancing Binary Code Similarity Detection via Context-Content Fusion and LLM Verification. <br></p><p dir="ltr">For more details, please refer to<i> </i><a href="https://github.com/GentleCP/Co2FuLL-public" rel="noreferrer" target="_blank">Github</a></p><p dir="ltr"><br></p>…”
  10. 50
  11. 51

    Research Data: Online Supplementary information od Wenzheng Li (22499069)

    Wydane 2025
    “…The validation data include the expression of AT1R and other receptors in HEK293 cells, verification of the HTRF-based ligand binding assay, and the effects of yeast-derived peptides on AT1R-mediated Gq dissociation and β-arrestin recruitment. …”
  12. 52
  13. 53
  14. 54
  15. 55

    Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas od Michael Kilian (16697663)

    Wydane 2025
    “…<p>Supplementary Figure 2: Molecular features of A2.DR1 MHC-humanized gliomas. A. Verification of the CRISPR-Cas9-mediated functional KO of p53 and Nf1 in the A2.DR1 glioma cell line. …”
  16. 56

    MARA: A Malware Analysis Reasoning Agent for Interpretable Android Malware Detection od 123 (11717522)

    Wydane 2025
    “…</p><h2> <b>Performance Highlights</b></h2><p dir="ltr">Across benchmark datasets (Drebin, AMD, CICMalDroid), MARA delivers:</p><ul><li><b>97.3% accuracy</b> on Drebin</li><li><b>96.4% accuracy</b> on AMD</li><li><b>94.7% accuracy</b> on CICMalDroid</li><li><b>Highest explanation quality</b> across clarity, semantic relevance, justification, and behavior-chain fidelity</li><li><b>Strong robustness</b> under obfuscation (renaming, packing, encryption)</li></ul><p dir="ltr">MARA consistently outperforms traditional static detectors, deep learning fusion models, and recent LLM-based malware analysis frameworks.…”
  17. 57

    The Male Primary Sex Ratio Bias in Goose Eggs Early in the Laying Season: A Pilot Study od Valeriy G. Narushin (17784130)

    Wydane 2025
    “…Using PCR technology for sex verification in this pilot study, we evaluated the primary sex ratio of 128 fertilized domestic goose eggs (<i>Anser anser</i>) early in the laying season. …”
  18. 58

    Timeline of therapeutic strategies in type 1 diabetes illustrating past, current, and emerging interventions. od Guy I. Sydney (22683459)

    Wydane 2025
    “…Emerging strategies include beta cell replacement, with genetic modifications of the transplanted cells, potentially in combination with a brief immune treatment, to avoid the need for chronic immune suppression, or even induction of beta cell regeneration. …”
  19. 59

    Proximity labeling of the intermediary protein AMOT between β-actin and YAP1 by STUPPIT. od Lin Xie (136792)

    Wydane 2025
    “…<p><b>(A)</b> Schematic representation of STUPPIT approach I with HEK293T cells stably expressing 3 × Flag-TbN-PupE. <b>(B, C)</b> Verification of 3 × Flag-TbN-PupE expression in HEK293T cells through immunofluorescence (B) and immunoblotting (C), scale bar 10 μm. …”
  20. 60

    Table 1_Barriers and facilitators to lifestyle behavior change and goal setting in adolescents with polycystic ovary syndrome.docx od Manasa Gadiraju (22675496)

    Wydane 2025
    “…Purpose<p>To identify barriers and facilitators to lifestyle modifications and goal setting and characterize goal setting for adolescents with polycystic ovary syndrome (PCOS).…”